Victory Capital Management Inc Pure Bioscience, Inc. Transaction History

Victory Capital Management Inc

  • $95.8 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 04, 2020
SELL
$0.28 - $0.72 $9 - $24
-34 Reduced 0.44%
7,760 $5,000
Q4 2019

Feb 04, 2020
BUY
$0.23 - $0.3 $1,792 - $2,338
7,794 New
7,794 $3,000

About PURE BIOSCIENCE, INC.

PURE Quotes by TradingView
  • Ticker PURE
  • Exchange OTC
  • Sector Consumer Defensive
  • Industry Household & Personal Products
  • Shares Outstandng 88,023,104
  • Market Cap $7.92M
  • Description
  • PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual prot...
More about PURE
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email